Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

This week Bobbi Conner talks with Dr. Miriam Alexander about advances in lung cancer treatment in recent years. Dr. Alexander ...

The team from Cancer Research UK's Manchester Institute says it has created a new in vitro model of lung squamous cell ...

The sector has seen billions in merger and acquisition activity in recent years; a September 2024 analysis by Insight ...

A phase 1/2 trial of CRISPR-engineered eTIL therapy KSQ-004EX for advanced solid tumors has dosed its first patient.

Therapies that unleash the immune system to fight tumors have greatly extended the lives of people with many types of cancer.

From new KRAS and HER2 inhibitors to home-administered immunotherapy, recent trials mark a turning point in how metastatic lung cancer is managed.

Why Many Lung Cancer Patients Who Have Never Smoked Have Worse Outcomes June 13, 2024 — The reason why targeted treatment for non-small cell lung cancer fails to work for some patients ...

Cancer Research scientists have developed a new cell-based model of lung squamous cell carcinoma (LUSC), a type of lung cancer, which has the potential to develop more effective treatments for the ...